We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

Featured Publishers

Publishers (3)

Lombardy Green Chemistry Association-LGCA is the reference point for the Lombard bioeconomy both at national and European level. LGCA is open to all Lombard stakeholders interested in the development of the bioeconomy and aims to: To create favourable conditions for the development of bioeconomy at regional level; To become the reference point and the interlocutor of regional and national authorities for the definition and implementation of policies to support innovation in the bioeconomy field; To establish a meeting and planning place for all Lombard subjects interested in the subject. The Association intends to dialogue with Europe to make visible the Lombardy's resources and expertise in the field of bioeconomy, to promote new business, collaboration and growth opportunities. In Italy, LGCA is a member of the National Technological Cluster of Green Chemistry-SPRING). In Europe, LGCA is an associate member of Vanguard Initiative Asbl, as it coordinates with the Lombardy Region the pilot "Bioeconomy" and participates in EUSALP-European Macro-regional Strategy for the Alpine Region.
Open
Our organisation is the event organizer of all Technical Conferences: all the best conferences in Italy.In the past we have organized the follow conferences:Windows Developer Conference Windows Server ConferenceSharePoint & Office Conference SQL Server & Business Intelligence Conference Unified Communications & Collaborations ConferenceVirtualization & Private Cloud ConferenceSharePoint Future
Open
The mission of Toscana Life Sciences (TLS) Foundation is to support research activities in the field of Life Sciences and, in particular, to foster the development of projects, from basic research to industrial application. TLS is especially committed to projects and activities aimed at discovering and developing orphan drugs, as well as improving existing therapies for rare and neglected diseases.
Open